ng-nitroarginine methyl ester has been researched along with Peripheral Vascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laughlin, MH; Li, Z; Lloyd, PG; Prior, BM; Taylor, JC; Terjung, RL; Yang, HT | 1 |
| Akita, T; Duan, J; Egami, K; Ikeda, H; Imaizumi, T; Murohara, T; Sasaki, K; Shimada, T; Shintani, S | 1 |
| Alkan, Z; Bilgen, I; Cirrik, S; Edremitlioğlu, M; Oner, G | 1 |
| Escalante, B; Guadarrama, JC; Jiménez Estrada, I; Luque Contreras, D; Martínez Fong, D; Paniagua Sierra, R; Rios, A; Segura, B; Vargas Robles, H | 1 |
| Lloyd, PG; Terjung, RL; Yang, HT | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Training-induced vascular adaptations to ischemic muscle.
Topics: Animals; Exercise Therapy; Exercise Tolerance; Humans; Intercellular Signaling Peptides and Proteins; Intermittent Claudication; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peripheral Vascular Diseases | 2008 |
4 other study(ies) available for ng-nitroarginine methyl ester and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation.
Topics: Administration, Oral; Animals; Cholesterol; Cholesterol, HDL; Cyclic GMP; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Folic Acid; Hindlimb; Homocysteine; Hypercholesterolemia; Ischemia; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peripheral Vascular Diseases; Rats; Rats, Sprague-Dawley; Risk Factors; Severity of Illness Index | 2003 |
Involvement of cholinoceptors in cadmium-induced endothelial dysfunction.
Topics: Acetylcholine; Administration, Oral; Animals; Aorta, Thoracic; Atropine; Cadmium; Calcimycin; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Gallamine Triethiodide; Glomerular Filtration Rate; Hypertension; Indomethacin; Kidney Cortex; Kidney Diseases; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroprusside; Peripheral Vascular Diseases; Phenylephrine; Pirenzepine; Prostaglandins; Rats; Rats, Wistar; Receptor, Muscarinic M1; Vasodilation | 2003 |
Hindlimb claudication reflects impaired nitric oxide-dependent revascularization after ischemia.
Topics: Animals; Arterial Occlusive Diseases; Biomechanical Phenomena; Blood Flow Velocity; Disease Models, Animal; Enzyme Induction; Enzyme Inhibitors; Gait; Hindlimb; Intermittent Claudication; Ischemia; Locomotion; Male; Muscle, Skeletal; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Rats; Rats, Wistar; Recovery of Function; RNA, Messenger; Time Factors | 2007 |
Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide.
Topics: Animals; Arterioles; Capillaries; Disease Models, Animal; Enzyme Inhibitors; Hindlimb; Ischemia; Kidney; Male; Muscle, Skeletal; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peripheral Vascular Diseases; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 2001 |